EP Patent

EP0931788B1 — Metalloprotease inhibitors

Assigned to Pfizer Ltd Great Britain · Expires 2002-11-06 · 24y expired

What this patent protects

Compounds of formula (I): <CHEM> where the substituents are as defined herein, and salts thereof, are matrix metalloprotease inhibitors.

USPTO Abstract

Compounds of formula (I): <CHEM> where the substituents are as defined herein, and salts thereof, are matrix metalloprotease inhibitors.

Drugs covered by this patent

Patent Metadata

Patent number
EP0931788B1
Jurisdiction
EP
Classification
—
Expires
2002-11-06
Drug substance claim
No
Drug product claim
No
Assignee
Pfizer Ltd Great Britain
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.